ATS Conference 2018 | 18-23 May | San Diego, CA

Not only will FLUIDDA present at the first Respiratory Innovation Summit at the American Thoracic Society conference 2018, we also have a strong scientific program with 7 Functional Respiratory Imaging  related presentations. Looking forward to seeing you at booth 2542!

 

Sunday, May 20

 

The Effect of the Aerobika® Oscillating PEP (OPEP) Device on Airway Structure, Function and Drug Deposition in Patients with COPD

Session A75 – COPD: Targets, Models, And Clinical Studies

11:15 AM – 1:00 PM

Area E, Hall A-B2

Ground Level – San Diego Convention Center

 

Monday, May 21

 

Changes in Ventilation-Perfusion During and After a COPD Exacerbation: An Assessment Using Fluid Dynamic Modelling

Session B64 –  COPD: Lung Function, Imaging And Pathophysiology

11:15 AM – 1:00 PM

Area L, Hall A-B2

Ground Level – San Diego Convention Center

 

Comparison of Inspiratory Capacity Assessed by Spirometry and Plethysmography: Post-Hoc Analysis of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Patients with COPD

Session B64 – COPD: Lung Function, Imaging and Pathophysiology

11:15 AM – 1:00 PM

Area L, Hall A-B2

Ground Level – San Diego Convention Center

 

Pulsed Inhaled Nitric Oxide (NO) Improves Exercise Tolerance in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients with Pulmonary Hypertension (PH)

Session B102 – Clinical Trials And Studies In COPD

2:15 PM – 4:15 PM

Room 30 C-E

Upper Level – San Diego Convention Center

 

Tuesday, May 22

 

Assessment of the Effects of GLPG1690 in Idiopathic Pulmonary Disease (IPF) Patients Using Functional Respiratory Imaging (FRI)

Session C97 –  Diffuse Parenchymal Lung Diseases: Evaluation, Outcomes, And Trials

3:45 PM – 4:00 PM

Grand Ballroom 5-6

North Tower, Lobby Level

– Marriott Marquis San Diego Marina

Functional Respiratory Imaging in Bronchopulmonary Dysplasia: A Novel Imaging Technique

Session C108 –  BPD And Other Congenital Lung Disease

2:15 PM – 4:15 PM

Room 6 E

Upper Level – San Diego Convention Center

Wednesday, May 23

 

Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-exacerbations in Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients (PII116678)

Session D12 –  Immunotherapy In Lung Disease

11:00 AM – 11:15 PM

Grand Ballroom 5-6

North Tower, Lobby Level – Marriott Marquis San Diego Marina

 

Sorry, comments are closed for this post.